What infusion rate of D5W (5% dextrose in water) should be used for a 70‑kg skilled‑nursing‑facility resident with chronic hypernatremia (serum sodium ≈160 mmol/L) who is hypovolemic but hemodynamically stable?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

D5W Infusion Rate for Chronic Hypernatremia with Hypovolemia

For a 70-kg patient with chronic hypernatremia (Na ≈160 mmol/L) who is hypovolemic but hemodynamically stable, start with normal saline (0.9% NaCl) at 100-200 mL/hour to restore volume first, then transition to D5W at 50-100 mL/hour once euvolemic, targeting a sodium correction rate of no more than 8-10 mmol/L per 24 hours.

Initial Volume Resuscitation

The critical first step is recognizing that hypovolemic hyponatremia (or hypernatremia with volume depletion) requires isotonic saline for volume restoration before addressing the sodium abnormality 1. The 2021 Gut guidelines explicitly state that hypovolemic states should be managed with normal saline to expand plasma volume 1. This applies even when sodium is elevated, because the priority is hemodynamic stability and tissue perfusion.

  • Administer 0.9% normal saline at 100-200 mL/hour initially
  • Monitor for clinical signs of euvolemia (improved skin turgor, mucous membrane hydration, stable vital signs)
  • Reassess volume status every 2-4 hours

Transition to D5W

Once the patient achieves euvolemia (typically after 1-2 liters of normal saline), transition to D5W for controlled sodium correction. The 2025 consensus on nephrogenic diabetes insipidus provides the clearest guidance: use 5% dextrose in water for intravenous rehydration 2.

Calculating the D5W Rate

For chronic hypernatremia (>48 hours duration), the correction rate must not exceed 8-10 mmol/L per 24 hours to prevent cerebral edema 3. More aggressive correction risks osmotic demyelination syndrome, even in hypernatremia 4.

Practical calculation for a 70-kg patient:

  • Total body water (TBW) = 0.5 × 70 kg = 35 L
  • Current Na = 160 mmol/L
  • Target Na after 24h = 152 mmol/L (8 mmol/L reduction)
  • Water deficit = TBW × [(Current Na / Target Na) - 1]
  • Water deficit = 35 × [(160/152) - 1] = 1.84 L

D5W infusion rate: 75-100 mL/hour (1.8-2.4 L over 24 hours)

Monitoring Protocol

The neurosurgical guidelines emphasize intensive monitoring during correction 3:

  • Check serum sodium every 2-4 hours during active correction
  • Monitor fluid balance (inputs/outputs) hourly
  • Daily weights
  • Adjust D5W rate if sodium drops faster than 0.5 mmol/L per hour

Critical Pitfalls to Avoid

Do not use D5W for initial resuscitation in hypovolemic patients. The anaphylaxis guidelines note that "dextrose is rapidly extravasated from the intravascular circulation to the interstitial tissues" 5, making it ineffective for volume expansion. This principle applies universally to hypovolemic states.

Avoid overcorrection. Recent research confirms that both parenteral D5W and enteral free water effectively lower sodium, with D5W showing slightly greater efficacy at -2.25 mEq/L per liter infused 6. This means a 70-kg patient receiving 2L of D5W could see a 4.5 mmol/L drop, which is appropriate for chronic hypernatremia.

Monitor for hyperglycemia. The 2022 systematic review on acute hypernatremia treatment identified hyperglycemia as the most common adverse event with dextrose-based solutions 7. Check blood glucose every 4-6 hours and consider insulin if glucose exceeds 180 mg/dL.

Special Considerations for Skilled Nursing Facility Residents

For elderly patients in long-term care with chronic hypernatremia:

  • Slower correction is safer: Target 6-8 mmol/L per 24 hours rather than 8-10 mmol/L
  • Consider adding loop diuretics if the patient becomes volume overloaded during correction 8
  • The 2008 research on hypervolemic hypernatremia demonstrates that combining D5W with furosemide allows negative sodium balance while correcting hypernatremia 8

Alternative Approach if D5W Unavailable

If D5W is not immediately available, the perioperative nutrition guidelines suggest maintenance fluids at 25-30 mL/kg/day (1,750-2,100 mL for 70 kg) with hypotonic solutions once euvolemic 9. However, D5W remains the preferred option per the 2025 expert consensus 2.

When to Escalate Care

Transfer to intensive care if 3:

  • Sodium >170 mmol/L
  • Mental status changes develop
  • Correction rate exceeds 1 mmol/L per hour despite rate adjustments
  • Patient becomes hemodynamically unstable

The key principle is sequential management: restore volume with normal saline first, then correct sodium slowly with D5W while monitoring intensively.

Related Questions

After administering 500 mL of 5% dextrose (D5W) to a patient with hypernatremia, when should the serum sodium be rechecked?
What hourly fluid volume and total duration are required to correct hypernatremia in a 115‑kg patient with acute pancreatitis, urine output 4800 mL per 24 hours, serum sodium 167 mEq/L, serum potassium 5.8 mEq/L, and eGFR 21 mL/min/1.73 m²?
Can a 5% dextrose (D5%) solution be used as the primary fluid for a 70‑kg adult patient with hypernatremia and a serum potassium level of 5.8 mmol/L?
In a patient with hypernatremia and normal serum potassium, should potassium be added to a D5 (5% dextrose) 0.45% NaCl (0.45% sodium chloride) infusion?
In an octogenarian or older patient with chronic heart failure and valvular disease who has poor oral intake and hypernatremia, should treatment with 5% dextrose in water (D5W) be used?
Can a 16 mm Tarlov cyst compressing the right S2 nerve root account for bilateral low back pain radiating to the buttocks and sacrum, leg weakness and heaviness, intermittent right foot dragging, left foot dysesthesia, numbness under the feet, constipation, weakened sphincter tone, vaginal vibrations, stable nocturia without incontinence, and nocturnal headaches?
How should a patient with a 5 mm distal ureteral stone presenting with pain be treated?
Can a patient taking quetiapine and escitalopram be prescribed isotretinoin?
What pathophysiologic changes occur in the body as a result of using trenbolone?
What are the recommended treatment guidelines for organizing pneumonia, including initial oral prednisone dosing, tapering schedule, and use of steroid-sparing agents?
What medications should be administered to prepare a patient for diagnostic coronary angiography and possible percutaneous coronary intervention (angioplasty)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.